Comment On "Predictors And Management Of Loss Of Response To Vedolizumab In Inflammatory Bowel Disease"

INFLAMMATORY BOWEL DISEASES(2019)

引用 52|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要